Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
7. 40
-0.06
-0.8043%
¥
2.59B Market Cap
- P/E Ratio
0.8% Div Yield
4.21M Volume
- Eps
¥ 7.46
Previous Close Want to track 603811 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
603811 closed today lower at ¥7.4, a decrease of -0.8043% from yesterday's close, completing a monthly increase of 0.1353% or ¥0.01. Over the past 12 months, 603811 stock lost -29.7246%.
603811 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 10 months on Jun 26, 2027 for a total of ¥0.3.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 26, 2026.
The company's stock is traded on one exchange.
603811 Chart
People also search for
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811) FAQ
What is the stock price today?
The current price is ¥7.40.
On which exchange is it traded?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 603811.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.8%.
What is its market cap?
As of today, the market cap is 2.59B.
Has Zhejiang Cheng Yi Pharmaceutical Co., Ltd. ever had a stock split?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Jun 26, 2026.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chunjian Zhao CEO | SSE Exchange | CNE100002YC7 ISIN |
| CN Country | 738 Employees | 26 Jun 2026 Last Dividend | 26 Jun 2026 Last Split | - IPO Date |
Overview
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. is a distinguished entity in the pharmaceutical sector, focusing on the manufacture and distribution of various pharmaceutical products. Originally established in 1966 as Wenzhou No. 3 Pharmaceutical Factory, the company underwent a significant rebranding in April 2001, adopting its current name. This transition marked a new phase in its commitment to healthcare and pharmaceutical innovation. Boasting a strategic location in Shanghai, China, Zhejiang Cheng Yi Pharmaceutical Co., Ltd. leverages its rich history and strategic position to serve the dynamic market demands within China and beyond.
Products and Services
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. offers a broad range of pharmaceutical products and services, including:
- APIs (Active Pharmaceutical Ingredients): The foundation of pharmaceutical manufacturing, these critical components are essential for the production of various drugs, underscoring the company’s pivotal role in the pharmaceutical supply chain.
- Injections: Specialized in sterile formulations, Zhejiang Cheng Yi Pharmaceutical provides a wide array of injectable medications, catering to numerous therapeutic areas and ensuring high standards of patient care.
- Capsules: The company manufactures capsules, encompassing a range of dosage forms designed to optimize therapeutic efficacy and patient compliance, showcasing their versatility in drug delivery technologies.
- Tablets: A classical form of medication, tablets produced by Zhejiang Cheng Yi Pharmaceutical are a testament to their commitment to providing reliable and accessible healthcare solutions.
- Pharmaceutical Intermediates: These compounds are crucial for the synthesis of APIs and final pharmaceutical products, highlighting the company's role in supporting the broader pharmaceutical manufacturing ecosystem.
Contact Information
Address: Shenhong Road, Building 20, Shanghai, China, 201100
Phone: 86 21 3328 3397
Website: https://www.chengyipharma.com
